Lost Money on JinkoSolar Holding Co., Ltd. (JKS)? Contact Levi & Korsinsky About Fraud Investigation
New York, New York--(Newsfile Corp. - April 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into JinkoSolar Holding Co., Ltd. ("JinkoSolar Holding Co., Ltd.") (NYSE: JKS) concerning potential violations of the federal securities laws. During the Q1 2025 earnings call on April 29, 2025, Charlie Cao, the CFO of principal operating subsidiary, Jinko Solar Co., Ltd., told analysts: "We expect the gross margin to improve and slightly in the second quarter...
2026-04-16 5:18 PM EDT
Lost Money on The Simply Good Foods Company (SMPL)? Contact Levi & Korsinsky to Protect Your Rights
New York, New York--(Newsfile Corp. - April 14, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into The Simply Good Foods Company ("The Simply Good Foods Company") (NASDAQ: SMPL) concerning potential violations of the federal securities laws. During the Q4 2025 earnings call on October 23, 2025, CEO Geoff Tanner told investors: "we're confident our gross margins will improve beginning modestly in Q3 and more meaningfully into Q4," and "are confident we will...
2026-04-14 2:42 PM EDT
Investigation Underway: Phreesia, Inc. (PHR) - Contact Levi & Korsinsky Over Securities Law Violations
New York, New York--(Newsfile Corp. - April 13, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential violations of the federal securities laws. On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million." Gandhi also stated that the recently acquired AccessOne would "contribute...
2026-04-13 12:47 AM EDT
Protect Your Investment: Contact Levi & Korsinsky About the Phreesia, Inc. (PHR) Investigation
New York, New York--(Newsfile Corp. - April 8, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE:PHR) concerning potential violations of the federal securities laws. On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million." Gandhi also stated that the recently acquired AccessOne would "contribute...
2026-04-08 10:56 AM EDT
PODD ALERT: Levi & Korsinsky Investigates Insulet Corporation on Behalf of Shareholders Who Lost Money
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Insulet Corporation (NASDAQ: PODD) ("Insulet Corporation") concerning potential violations of the federal securities laws. During that same February 18 earnings call, McEvoy stated that "strong clinical evidence and real-world outcomes continue to earn prescriber and patient confidence" and described Omnipod 5 as the "favorite pump" for both type-1 and type-2...
2026-04-06 12:42 AM EDT
Investors in Disc Medicine, Inc. (IRON) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. (NASDAQ: IRON) ("Disc Medicine, Inc.") concerning potential violations of the federal securities laws. On February 13, 2026, Disc disclosed that the FDA had issued a Complete Response Letter (CRL) for bitopertin, the company's lead therapeutic candidate targeting EPP, a rare genetic disorder characterized by extreme photosensitivity. A CRL...
2026-04-06 12:39 AM EDT
Investigation Opened on Behalf of ADMA Biologics, Inc. (ADMA) Shareholders - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) ("ADMA Biologics, Inc.") concerning potential violations of the federal securities laws. On the Q4 2025 earnings call, CEO Adam Grossman stated "ASCENIV achieved $363 million in net revenue, representing 51% year-over-year growth." Culper Research's short report contends ASCENIV only achieved its growth on the back of...
2026-04-06 12:36 AM EDT
Potential Securities Fraud: Levi & Korsinsky Investigates Freshpet, Inc. (FRPT)
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Freshpet, Inc. (NASDAQ: FRPT) ("Freshpet, Inc.") concerning potential violations of the federal securities laws. On March 17, 2026, an NAD ruling came through after a Fast-Track SWIFT challenge, an expedited single-issue process, was brought by one of Freshpet's competitors, The Farmer's Dog. The Farmer's Dog argued that three of Freshpet's video ads included...
2026-04-06 12:19 AM EDT
Investors in Immutep Limited (IMMP) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited (NASDAQ:IMMP) ("Immutep Limited") concerning potential violations of the federal securities laws. On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analysis was "on track for the first quarter of CY2026" and cited "strong operational progress" for the trial. The filing contained no reference to negative...
2026-04-06 12:12 AM EDT
Investors in Phreesia, Inc. (PHR) Warned of Potential Securities Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - April 1, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Phreesia, Inc. ("Phreesia, Inc.") (NYSE: PHR) concerning potential violations of the federal securities laws. On December 8, 2025, CFO Balaji Gandhi told investors on the Q3 2026 earnings call: "For fiscal year 2027, we expect revenue to be in the range of $545 million to $559 million." Gandhi also stated that the recently acquired AccessOne would "contribute...
2026-04-01 11:45 AM EDT
Ongoing Securities Investigation into Freshpet, Inc. (FRPT) - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Freshpet, Inc. (NASDAQ: FRPT) ("Freshpet, Inc.") concerning potential violations of the federal securities laws. On March 17, 2026, an NAD ruling came through after a Fast-Track SWIFT challenge, an expedited single-issue process, was brought by one of Freshpet's competitors, The Farmer's Dog. The Farmer's Dog argued that three of Freshpet's video ads included...
2026-03-30 4:14 AM EDT
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Disc Medicine, Inc. (IRON)
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Disc Medicine, Inc. ("Disc Medicine, Inc.") (NASDAQ: IRON) concerning potential violations of the federal securities laws. On February 13, 2026, Disc disclosed that the FDA had issued a Complete Response Letter (CRL) for bitopertin, the company's lead therapeutic candidate targeting EPP, a rare genetic disorder characterized by extreme photosensitivity. A CRL...
2026-03-30 12:30 AM EDT
Lost Money on Immutep Limited (IMMP)? Possible Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited ("Immutep Limited") (NASDAQ: IMMP) concerning potential violations of the federal securities laws. On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analysis was "on track for the first quarter of CY2026" and cited "strong operational progress" for the trial. The filing contained no reference to negative...
2026-03-30 12:14 AM EDT
Did Aldeyra Therapeutics, Inc. (ALDX) Mislead Investors? Levi & Korsinsky Investigates
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aldeyra Therapeutics, Inc. ("Aldeyra Therapeutics, Inc.") (NASDAQ: ALDX) concerning potential violations of the federal securities laws. Throughout 2024 and 2025, Aldeyra's made forward-looking statements regarding the development and regulatory prospects of reproxalap for the treatment of dry eye disease. Management described the NDA submission and review...
2026-03-30 12:12 AM EDT
Levi & Korsinsky Launches Fraud Investigation on Behalf of ADMA Biologics, Inc. (ADMA) Shareholders
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ: ADMA) concerning potential violations of the federal securities laws. On the Q4 2025 earnings call, CEO Adam Grossman stated "ASCENIV achieved $363 million in net revenue, representing 51% year-over-year growth." Culper Research's short report contends ASCENIV only achieved its growth on the back of...
2026-03-30 12:10 AM EDT
ATTENTION Insulet Corporation (PODD) Investors: Possible Fraud - Contact Levi & Korsinsky Today
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Insulet Corporation ("Insulet Corporation") (NASDAQ: PODD) concerning potential violations of the federal securities laws. During that same February 18 earnings call, McEvoy stated that "strong clinical evidence and real-world outcomes continue to earn prescriber and patient confidence" and described Omnipod 5 as the "favorite pump" for both type-1 and type-2...
2026-03-30 12:08 AM EDT
GOSS ALERT: Ongoing Investigation Into Gossamer Bio, Inc. - Contact Levi & Korsinsky
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Gossamer Bio, Inc. ("Gossamer Bio, Inc.") (NASDAQ: GOSS) concerning potential violations of the federal securities laws. Seralutinib was Gossamer Bio's lead pipeline candidate and the PROSERA study was the Company's pivotal Phase 3 trial evaluating the drug in pulmonary arterial hypertension. The Company had publicly characterized the PROSERA patient...
2026-03-30 12:06 AM EDT
Fraud Investigation: Levi & Korsinsky Investigates Aldeyra Therapeutics, Inc. (ALDX) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - March 27, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aldeyra Therapeutics, Inc. ("Aldeyra Therapeutics, Inc.") (NASDAQ: ALDX) concerning potential violations of the federal securities laws. Throughout 2024 and 2025, Aldeyra's made forward-looking statements regarding the development and regulatory prospects of reproxalap for the treatment of dry eye disease. Management described the NDA submission and review...
2026-03-27 3:38 PM EDT
Did You Suffer Losses in ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky About Securities Fraud Claims
New York, New York--(Newsfile Corp. - March 27, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ: ADMA) concerning potential violations of the federal securities laws. On the Q4 2025 earnings call, CEO Adam Grossman stated "ASCENIV achieved $363 million in net revenue, representing 51% year-over-year growth." Culper Research's short report contends ASCENIV only achieved its growth on the back of...
2026-03-27 11:50 AM EDT
Fraud Investigation Opened: Levi & Korsinsky Investigates Freshpet, Inc. (FRPT) on Behalf of Shareholders
New York, New York--(Newsfile Corp. - March 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Freshpet, Inc. ("Freshpet, Inc.") (NASDAQ: FRPT) concerning potential violations of the federal securities laws. On March 17, 2026, an NAD ruling came through after a Fast-Track SWIFT challenge, an expedited single-issue process, was brought by one of Freshpet's competitors, The Farmer's Dog. The Farmer's Dog argued that three of Freshpet's video ads included...
2026-03-25 9:47 AM EDT